Glenn W. Welling
Engaged Capital
Glenn W. Welling Puma Biotechnology Inc stake
total: 101
Engaged Capital PBYI trades
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2018 Q3
- Held for:
- 1 quarter
- Latest activity:
- 2018 Q4
According to 2026 Q2 report, Glenn W. Welling doesn't hold any Puma Biotechnology Inc (PBYI) shares. To date, the estimated cost basis is nearly $45.85 for "buy" trades and estimated average "sell" price is $45.85. Engaged Capital first purchased PBYI in 2018 Q3, initially acquiring 151,689 shares. Since the initial investment in Puma Biotechnology Inc (PBYI), Engaged Capital has made 1 more transaction.
When did Glenn W. Welling sell Puma Biotechnology Inc (PBYI)?
Glenn W. Welling sold off the entire Puma Biotechnology Inc (PBYI) position in 2018 Q4.
When did Glenn W. Welling buy Puma Biotechnology Inc (PBYI)?
Glenn W. Welling first invested in Puma Biotechnology Inc (PBYI) in 2018 Q3 at the reported quarter-end price of $45.85 per share.
What's the cost basis of Engaged Capital's PBYI stake?
The estimated cost basis for Puma Biotechnology Inc (PBYI) stake is around $45.85 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $45.85
- Weighted AVG sell price:
- $45.85
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.